Aytu BioPharma Inc (AYTU)
2.91
+0.07
(+2.46%)
USD |
NASDAQ |
Apr 26, 11:41
Aytu BioPharma Price to Book Value: 0.4932 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.4813 |
| April 24, 2024 | 0.4745 |
| April 23, 2024 | 0.4601 |
| April 22, 2024 | 0.4762 |
| April 19, 2024 | 0.4728 |
| April 18, 2024 | 0.4728 |
| April 17, 2024 | 0.4869 |
| April 16, 2024 | 0.4847 |
| April 15, 2024 | 0.4542 |
| April 12, 2024 | 0.4898 |
| April 11, 2024 | 0.5287 |
| April 10, 2024 | 0.5451 |
| April 09, 2024 | 0.5694 |
| April 08, 2024 | 0.5593 |
| April 05, 2024 | 0.5457 |
| April 04, 2024 | 0.5423 |
| April 03, 2024 | 0.5304 |
| April 02, 2024 | 0.5135 |
| April 01, 2024 | 0.5067 |
| March 28, 2024 | 0.5152 |
| March 27, 2024 | 0.522 |
| March 26, 2024 | 0.522 |
| March 25, 2024 | 0.5177 |
| March 22, 2024 | 0.5152 |
| March 21, 2024 | 0.505 |
| Date | Value |
|---|---|
| March 20, 2024 | 0.4898 |
| March 19, 2024 | 0.4847 |
| March 18, 2024 | 0.4898 |
| March 15, 2024 | 0.4864 |
| March 14, 2024 | 0.4864 |
| March 13, 2024 | 0.5169 |
| March 12, 2024 | 0.5338 |
| March 11, 2024 | 0.5338 |
| March 08, 2024 | 0.5321 |
| March 07, 2024 | 0.5211 |
| March 06, 2024 | 0.5076 |
| March 05, 2024 | 0.5152 |
| March 04, 2024 | 0.4999 |
| March 01, 2024 | 0.5016 |
| February 29, 2024 | 0.4898 |
| February 28, 2024 | 0.5016 |
| February 27, 2024 | 0.4813 |
| February 26, 2024 | 0.4898 |
| February 23, 2024 | 0.4965 |
| February 22, 2024 | 0.5016 |
| February 21, 2024 | 0.5101 |
| February 20, 2024 | 0.5559 |
| February 16, 2024 | 0.5372 |
| February 15, 2024 | 0.5287 |
| February 14, 2024 | 0.5338 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1413
Minimum
May 05 2023
10.59
Maximum
Mar 24 2020
1.38
Average
0.6139
Median
Price to Book Value Benchmarks
| Regen BioPharma Inc | -- |
| Clearday Inc | -- |
| Bioxytran Inc | -- |
| Shuttle Pharmaceuticals Holdings Inc | 1.653 |
| CEL-SCI Corp | 6.166 |
Price to Book Value Related Metrics
| PS Ratio | 0.1387 |
| Price to Free Cash Flow | 2.236 |
| Price | 2.91 |
| Earnings Yield | -138.8% |
| Market Cap | 16.20M |